CDXS logo

CDXS
Codexis Inc.

2,353
Mkt Cap
$148.12M
Volume
1.49M
52W High
$3.87
52W Low
$0.9583
PE Ratio
-3.15
CDXS Fundamentals
Price
$1.74
Prev Close
$1.63
Open
$1.66
50D MA
$1.37
Beta
2.03
Avg. Volume
1.28M
EPS (Annual)
-$0.5046
P/B
2.92
Rev/Employee
$482,102.74
$136.56
Loading...
Loading...
News
all
press releases
Short Interest in Codexis, Inc. (NASDAQ:CDXS) Grows By 26.2%
Codexis, Inc. (NASDAQ:CDXS - Get Free Report) saw a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling 9,161,843 shares, an...
MarketBeat·17d ago
News Placeholder
More News
News Placeholder
Codexis (NASDAQ:CDXS) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen upgraded shares of Codexis from a "strong sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·19d ago
News Placeholder
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours?
Codexis shares jumped 37.8% in after-hours trading after the company reported a profitable fourth quarter and full-year 2025 revenue growth.read more...
Benzinga·21d ago
News Placeholder
Codexis (CDXS) Q4 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·21d ago
News Placeholder
Codexis Q4 Earnings Call Highlights
Codexis (NASDAQ:CDXS) used its fourth-quarter and full-year 2025 earnings call to highlight progress behind its strategic focus on RNA medicines, with management emphasizing technical milestones for...
MarketBeat·21d ago
News Placeholder
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of +2,100.00% and +1.61%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·21d ago
News Placeholder
Codexis (NASDAQ:CDXS) Releases Earnings Results, Beats Expectations By $0.10 EPS
Codexis (NASDAQ:CDXS - Get Free Report) announced its quarterly earnings results on Wednesday. The biotechnology company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.01 by...
MarketBeat·21d ago
News Placeholder
Codexis Targets 2026 Inflection as CEO Touts ECO Synthesis Push in RNA Manufacturing at TD Cowen Conf
Codexis (NASDAQ:CDXS) President and CEO Alison Moore outlined the company's strategic focus on RNA medicines manufacturing at TD Cowen's 46th Annual Health Care Conference, emphasizing expected...
MarketBeat·25d ago
News Placeholder
Liquidia Corporation (LQDA) Surpasses Q4 Earnings and Revenue Estimates
Liquidia Corporation (LQDA) delivered earnings and revenue surprises of +100.00% and +19.34%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·27d ago
News Placeholder
Why Did CDXS Stock Jump 7% Today?
The company tied up with an innovator pharmaceutical company to manufacture 50 grams of small interfering RNA using a proprietary ECO Synthesis platform.
Stocktwits·28d ago
<
1
2
...
>

Latest CDXS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.